Prognostic value of ABO blood group in patients with surgically resected colon cancer

被引:44
作者
Cao, X. [1 ]
Wen, Z-S [1 ,2 ]
Sun, Y-J [3 ]
Li, Y. [1 ,4 ]
Zhang, L. [1 ,5 ]
Han, Y-J [1 ,6 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Surg Oncol, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Clin Lab, Guangzhou 510060, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Ctr Canc, Dept Preclin Med, Guangzhou 510060, Guangdong, Peoples R China
关键词
ABO blood type; colon cancer; prognosis; survival; CARBOHYDRATE ANTIGENS; EXPRESSION; CARCINOMA; SELECTIN; RISK; TNF;
D O I
10.1038/bjc.2014.302
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Previous studies supported a link between the ABO blood type and survival for several types of malignancies. Nonetheless, the relationship between ABO blood type and survival in colon cancer patients has not been rigorously evaluated. The goal of this retrospective analysis was to discern the correlations between ABO blood group and colon cancer survival. Methods: A total of 1555 colon cancer patients that underwent curative-intent surgery between October 1995 and June 2002 were eligible for this study. The primary outcomes measured were the association between ABO blood group and patient survival. Results: Compared with patients with non-AB blood types (blood types A, B, and O), patients with blood type AB were more likely to have better survival. The mean overall survival (OS) of the blood type AB patients was 113.9 months, whereas the mean OS of the non-AB blood type patients was significantly lower, 106.1 months (P<0.001, log-rank test). Compared with patients with blood type AB, the hazard ratios for patients with A, B, and O were 4.37 (95% confidence interval (95% CI), 2.65-7.20), 2.99 (95% CI, 1.81-4.96), and 2.78 (95% CI, 1.69-4.56), respectively. Conclusions: Blood type AB is a favourable prognostic factor for patients with colon cancer.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 28 条
[1]   Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels [J].
Barbalic, Maja ;
Dupuis, Josee ;
Dehghan, Abbas ;
Bis, Joshua C. ;
Hoogeveen, Ron C. ;
Schnabel, Renate B. ;
Nambi, Vijay ;
Bretler, Monique ;
Smith, Nicholas L. ;
Peters, Annette ;
Lu, Chen ;
Tracy, Russell P. ;
Aleksic, Nena ;
Heeriga, Jan ;
Keaney, John F., Jr. ;
Rice, Kenneth ;
Lip, Gregory Y. H. ;
Vasan, Ramachandran S. ;
Glazer, Nicole L. ;
Larson, Martin G. ;
Uitterlinden, Andre G. ;
Yamamoto, Jennifer ;
Durda, Peter ;
Haritunians, Talin ;
Psaty, Bruce M. ;
Boerwinkle, Eric ;
Hofman, Albert ;
Koenig, Wolfgang ;
Jenny, Nancy S. ;
Witteman, Jacqueline C. ;
Ballantyne, Christie ;
Benjamin, Emelia J. .
HUMAN MOLECULAR GENETICS, 2010, 19 (09) :1863-1872
[2]  
COSTANTINI M, 1990, ONCOLOGY-BASEL, V47, P308
[3]  
DAVIDSOHN I, 1972, AM J CLIN PATHOL, V57, P715
[4]   ABO blood group and breast cancer incidence and survival [J].
Gates, Margaret A. ;
Xu, Mousheng ;
Chen, Wendy Y. ;
Kraft, Peter ;
Hankinson, Susan E. ;
Wolpin, Brian M. .
INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) :2129-2137
[5]  
Greene F.L., 2002, AJCC CANC STAGING MA, V6th
[6]  
Hakomori S, 2001, ADV EXP MED BIOL, V491, P369
[7]   Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer [J].
Hakomori, S .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1473 (01) :247-266
[8]   BLOOD-GROUP AS A PROGNOSTIC INDICATOR IN BREAST-CANCER [J].
HOLDSWORTH, PJ ;
THOROGOOD, J ;
BENSON, EA ;
CLAYDEN, AD .
BRITISH MEDICAL JOURNAL, 1985, 290 (6469) :671-673
[9]   DISTRIBUTION OF ABO BLOOD GROUPS IN PATIENTS WITH PERNICIOUS ANEMIA GASTRIC CARCINOMA AND GASTRIC CARCINOMA ASSOCIATED WITH PERNICIOUS ANEMIA [J].
HOSKINS, LC ;
LOUX, HA ;
BRITTEN, A ;
ZAMCHECK, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (12) :633-&
[10]  
ITZKOWITZ SH, 1987, JNCI-J NATL CANCER I, V79, P425